The supplement you swallowed probably didn't arrive

Every morning, millions of people swallow a carefully chosen handful of supplements and then go about their day assuming the work is done. Yet the dose printed on the label and the dose that actually reaches a cell are rarely the same number — and for many common formulations, the gap is striking.

The measure that matters here is bioavailability: the fraction of an ingested nutrient that enters systemic circulation and reaches target tissues. It is a percentage, not a promise, and it is determined not by what is in the capsule but by what the body can do with it after you swallow. Intravenous delivery achieves 100% bioavailability by definition. Every oral route falls somewhere short of that — often significantly so.

The reason is not a single flaw but a compounding pipeline failure. Between swallowing a tablet and a nutrient arriving at a cell, at least four sequential chokepoints must be cleared. Each one reduces what gets through. Professor Paul Lee, whose Regeneration by Design frames health optimisation around four interdependent pillars, positions this squarely within Chemistry: the body's internal environment determines which molecules it can actually use, and delivery method is as consequential as content.

Four barriers standing between the capsule and your cells

Think of the journey from capsule to cell as a gauntlet with four gates — and the nutrient must clear every one of them.

The first is dissolution. A hard-pressed tablet is held together by binders and fillers designed for shelf stability, not rapid breakdown. If the tablet has not fully dissolved by the time it passes the small intestine's absorptive window, what remains simply continues south. Liquid, softgel, and powder formats are less prone to this, but even well-formulated capsules face what follows.

The second gate is the gut environment itself. Low stomach acid — common as people age, and a side-effect of widely prescribed proton-pump inhibitors — means some nutrients are not adequately activated before they reach the intestine. Inflammation in the gut lining, or a dysbiotic microbiome, further degrades absorptive capacity. These are not unusual clinical conditions; they are normal biological variables that shift quietly over the course of adult life.

The third is the intestinal wall. Plant-derived foods and many fibre-rich supplements contain phytates that bind minerals before they can cross into the bloodstream. A damaged or inflamed gut lining also reduces the active transport mechanisms that move nutrients from the intestinal lumen into circulation. The wall, in short, is selective — and not always in the supplement's favour.

The fourth gate is the liver. Everything absorbed from the gut travels via the portal vein directly to hepatic processing before it reaches systemic circulation. The liver does not read supplement labels. It applies the same enzymatic scrutiny to a high-quality magnesium chelate as it does to anything else crossing that threshold, metabolising a meaningful proportion before the nutrient reaches the rest of the body. Patchworks UK describes the effect plainly: around half of UK adults take supplements daily, yet the labelled dose is very unlikely to reach the bloodstream intact.

Chemical form is doing most of the work

Assume all four gates have been cleared. The nutrient is in circulation. How much of it actually arrived still depends on a variable that precedes everything else: the molecular form the manufacturer chose.

Magnesium is the clearest illustration. Magnesium oxide — the form found in many budget formulations — is absorbed at roughly 4%. Chelated forms, where the mineral is bound to an amino acid such as glycine or malic acid, are absorbed substantially more efficiently. The milligram count on the front of the bottle is identical; the yield at the cell is not.

The same logic runs across nutrients. Fat-soluble vitamins — A, D, E, and K — require co-ingested dietary fat to cross the intestinal wall at all. Swallowed on an empty stomach, much of the dose passes through unused. Between two forms of the same vitamin, the active form often outperforms the precursor markedly: calcifediol, the active vitamin D metabolite, raises serum levels more reliably than cholecalciferol. Methylfolate — the form the body can use directly — is more bioavailable than synthetic folic acid, which requires an enzymatic conversion step that genetic variants in the MTHFR pathway can impair.

Professor Paul Lee frames this as a design problem in Practical Regeneration (the systems-focused companion to his Amazon number-one Regeneration by Design): the formulator's choice of molecular form sets the ceiling on possible absorption before the bottle is ever opened. Within the Chemistry pillar, ingredient form and formulation intelligence are as consequential as the decision to supplement at all.

Why the problem gets worse with age — and with common medications

Metformin, prescribed to millions across the UK for metabolic health management, is well-documented to deplete vitamin B12 — progressively, over months and years of use. For anyone taking it alongside a B12 supplement, the net delivery to cells may be considerably lower than the label suggests. This is one instance of a broader pattern: the absorption pipeline does not hold steady over time. Several forces converge to narrow it, often simultaneously.

Stomach acid production declines gradually with age — a process called hypochlorhydria — reducing the body's ability to cleave B12 from food proteins and to activate other nutrients before they reach the small intestine. Proton pump inhibitors (PPIs), among the most dispensed drugs in UK primary care, suppress this acid further. Used consistently, they may compound what age has already reduced, and both effects sit largely beneath conscious awareness.

Gut dysbiosis — an imbalance in the microbiome's bacterial composition — is increasingly common in this demographic, and it matters here because a healthy microbiota actively supports the uptake of vitamins and minerals. Studies confirm that bacterial overgrowth and dysbiosis reduce the availability of several vitamins, independently of what the supplement contains.

The practical implication connects directly to the Time pillar in Professor Paul Lee's Regeneration by Design framework: a routine that felt adequate at 40 may be quietly underdelivering at 55. Discussing any regular PPI or metformin use with a GP or clinician is worth doing — not to change medication, but to understand what monitoring might be warranted. Tracking what is actually reaching circulation, rather than what is printed on the bottle, is where that gap becomes visible and actionable.

Better oral delivery and when IV changes the equation

Three practical responses to the absorption problem exist, each addressing more of the pipeline than the last.

Form and timing first. Without changing format at all, much can be improved: choosing chelated minerals over oxide forms, taking fat-soluble vitamins (A, D, E, K) with a fat-containing meal, spacing iron and calcium supplementation apart to avoid competing for the same intestinal transporter, and using sublingual B12 when gut absorption is compromised. None of these require a new product — just more precise use of what is already on the shelf.

Liposomal formulations as the oral upgrade. A standard capsule is essentially unprotected cargo passing through a hostile environment. Liposomal supplements wrap each nutrient in a phospholipid vesicle — a structure that mimics the cell membrane — which resists stomach acid and digestive enzymes, then delivers its contents via endocytosis or passive diffusion across the intestinal wall. Pharmacokinetic data places the difference at 2–5 times higher plasma concentrations compared with conventional equivalents; a 2025 ScienceDirect study confirmed this pattern for liposomal vitamin C against standard oral forms. Some comparisons cite up to 30-fold improvement — those figures represent upper-bound claims for specific nutrients under optimal conditions, not a realistic average across the board. Product quality also varies considerably: phospholipid purity and vesicle stability determine whether the mechanism works at all, so not all liposomal labels are equivalent.

IV as the ceiling. Even a well-formulated liposomal supplement is still subject to the GI tract. Intravenous delivery removes the pipeline entirely: nutrients enter systemic circulation directly, at clinically meaningful concentrations, achieving 100% bioavailability by definition.

Regen365 IV sits at this end of the spectrum — and readers should know it is Regen PhD's own clinician-led formulation, not a neutral third-party comparison. Developed by Professor Paul Lee and refined over more than a decade, it is positioned within the Chemistry pillar of Practical Regeneration (2026) as a precision delivery layer: an adjunct for those seeking measurable results at the cellular level, not a replacement for nutrition, movement, or sleep. Sessions run approximately twenty minutes and are designed to pair with biomarker monitoring through Regen OS, so what reaches circulation can be tracked rather than assumed.

The practical ladder, then: start with form and timing, consider liposomal formats for consistently poor absorbers, and discuss IV with a clinician if the goal is confirmed delivery at meaningful concentrations. Each step earns its place because the one before it has a ceiling.

What to actually change this week

A few targeted changes can shift how much of what is already on the shelf actually arrives.

Start with the label. Check the form of any mineral supplement: magnesium oxide, calcium carbonate, and iron sulphate sit at the low end of the absorption range. Swapping to chelated equivalents — glycinate, citrate, bisglycinate — requires no prescription and usually costs roughly the same. For fat-soluble vitamins (A, D, E, and K), the most common error is taking them fasted: pair them with a meal containing olive oil, eggs, or avocado to unlock absorption.

Adjust timing and sequencing. Not every supplement belongs at the same moment. Minerals sharing an intestinal transporter are better spread across meals, and sublingual B12 bypasses the stomach entirely if gut function is uncertain — worth noting for anyone on a PPI long-term.

Consider liposomal formats for vitamin C and key B vitamins when gut health is a known concern. Phospholipid purity and vesicle stability determine whether the mechanism actually works, so look beyond the label rather than assuming all liposomal products are equivalent.

Use biomarker data to personalise. Blood panels — via Regen OS or a comparable monitoring tool — turn guesswork into targeted adjustment, identifying specific gaps rather than layering supplements speculatively. This is the Chemistry pillar working as it should: informed, not approximate.

Discuss IV delivery with a clinician if the goal is confirmed delivery at clinically meaningful concentrations. Regen365 IV sits within Professor Paul Lee's Regeneration by Design system as a precision Chemistry-pillar intervention for those who want to close the bioavailability gap directly, rather than navigate the oral pipeline's compounding uncertainties.

Gut integrity shapes absorption, absorption shapes what monitoring reveals, and monitoring feeds back into the timing and form decisions that run across the Chemistry, Biology, and Time pillars simultaneously. That interdependence is the point.

For any clinical concerns — including medication interactions or known nutrient deficiencies — please consult a qualified healthcare professional.

1. [1] Bioavailability — Wikipedia. https://en.wikipedia.org/?curid=769021 https://en.wikipedia.org/?curid=769021